Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Edward R Ashwood"'
Autor:
Brandon S Walker, Richard E Nelson, Brian R Jackson, David G Grenache, Edward R Ashwood, Robert L Schmidt
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0131402 (2015)
Non-invasive prenatal testing (NIPT) is a relatively new technology for diagnosis of fetal aneuploidies. NIPT is more accurate than conventional maternal serum screening (MSS) but is also more costly. Contingent NIPT may provide a cost-effective alte
Externí odkaz:
https://doaj.org/article/347481f0e2cf4fb0897a1c77fd98c77c
Publikováno v:
Clinical Chemistry. 68:1578-1579
Autor:
Nathalie Lepage, Glenn E. Palomaki, Rhona J. Souers, Edward R. Ashwood, Philip Wyatt, Robert G. Best, John A. Thorson
Publikováno v:
Genetics in Medicine. 22:777-784
Summarize and interpret results from exercises distributed to laboratories offering cell-free (cf) DNA screening for Down syndrome. The College of American Pathologists distributed three patient-derived plasma specimens twice in 2018. Sequencing plat
Autor:
Philip Wyatt, Nathalie Lepage, Thomas A. Long, Robert G. Best, Edward R Ashwood, Glenn E. Palomaki
Publikováno v:
Journal of medical screening. 28(4)
Objective To compile current usage of serum-based prenatal screening for Down syndrome in the United States and compare it with results from a similar 2011/2012 survey. Setting The College of American Pathologists maternal screening proficiency testi
Autor:
Glenn E, Palomaki, Philip, Wyatt, Robert Glen, Best, Nathalie, Lepage, Edward R, Ashwood, Rhona J, Souers, John A, Thorson
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics. 22(4)
Summarize and interpret results from exercises distributed to laboratories offering cell-free (cf) DNA screening for Down syndrome.The College of American Pathologists distributed three patient-derived plasma specimens twice in 2018. Sequencing platf
Autor:
Susan Evans, Charles S. Eby, Norman Moore, Harvey W. Kaufman, Nader Rifai, Edward R. Ashwood, Kerri Weinert, Peter Gyorda
Publikováno v:
Clinical Chemistry. 61:1320-1327
Over the past 20 years, there has been a continuous shift in decentralizing clinical laboratory testing in the US. Historically, testing was conducted almost exclusively in centralized laboratories in hospitals. However, at present, approximately 53%
Autor:
George J. Knight, Glenn E. Palomaki, Geralyn Lambert-Messerlian, Robert G. Best, Edward R. Ashwood
Publikováno v:
Genetics in Medicine. 17:897-900
We sought to determine whether tests for fetal aneuploidy based on next-generation sequencing of cell-free DNA in maternal circulation have had an impact on routine serum-based screening in the general pregnant population. We compared results from la
Publikováno v:
Prenatal Diagnosis. 35:440-446
Objective The aim of this article is to determine the cost effectiveness of cell free DNA (cfDNA) as a replacement forintegrated screening using a societal cost perspective. Method This study used Monte-Carlo simulation with one-way and probabilistic
Publikováno v:
American Journal of Clinical Pathology. 149:S191-S192
Publikováno v:
Prenatal Diagnosis. 33:1201-1206
Objectives In maternal serum screening for Down syndrome, a cutoff of 1 : 270 is often used as a decision point to recommend invasive confirmatory testing. However, it has not been established how well this or any other cutoff relates to patient pref